Cytel to acquire SDS Life Science and SDS MedteQ
Cytel has announced an agreement to acquire SDS Life Science AB and SDS MedteQ AB - bolstering expertise in strategic therapeutic development
Cytel has announced an agreement to acquire SDS Life Science AB and SDS MedteQ AB - bolstering expertise in strategic therapeutic development
Cytel has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development
Cytel has announced that Bayesian clinical trial design specialist Dr Kyle Wathen has joined Cytel as vice president of scientific strategy and innovation
We round up the latest laboratory software tools to help streamline laboratory operations in 2023
We round up the latest cluster management software tools available to scientists and researchers using HPC
A round-up of the latest processing and memory technologies